Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Butzkueven

Showing results (131-140 of 390) with videos related to

Pageof 39
Sort By:
Plos One|June 13, 2015
The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene FunctionJudith Field, Fernando Shahijanian, Stephen Schibeci, et al.
Journal of the Neurological Sciences|February 26, 2011
Brain plasticity in relapsing-remitting multiple sclerosis: evidence from resting-state fMRIYaou Liu, Peipeng Liang, Yunyun Duan, et al.
Brain Sciences|September 28, 2021
Developing a Digital Solution for Remote Assessment in Multiple Sclerosis: From Concept to Software as a Medical DeviceAnneke van der Walt, Helmut Butzkueven, Robert K Shin, et al.
Autoimmunity Reviews|October 15, 2018
What speech can tell us: A systematic review of dysarthria characteristics in Multiple SclerosisGustavo Noffs, Thushara Perera, Scott C Kolbe, et al.
Plos One|March 13, 2026
Study protocol for a mixed methods convergent investigation of family domestic and sexual violence in multiple sclerosis and broader neurology in AustraliaCassie Nesbitt, Genevieve Rayner, Kristen Timmens, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
A role for galanin in human and experimental inflammatory demyelinationDavid C Wraith, Robert Pope, Helmut Butzkueven, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2021
Early treatment delays long-term disability accrual in RRMS: Results from the BMSD networkPietro Iaffaldano, Giuseppe Lucisano, Helmut Butzkueven, et al.
European Radiology|July 2, 2017
Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MSYaou Liu, Yunyun Duan, Jing Huang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 16, 2008
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelinationMichele D Binder, Holly S Cate, Anne L Prieto, et al.
Current Medical Research and Opinion|September 7, 2023
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosisHelmut Butzkueven, Jan Hillert, Merja Soilu-Hänninen, et al.
Pageof 39

Showing results (131-140 of 390) with videos related to

Sort By:
Pageof 39
Plos One|June 13, 2015
The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene FunctionJudith Field, Fernando Shahijanian, Stephen Schibeci, et al.
Journal of the Neurological Sciences|February 26, 2011
Brain plasticity in relapsing-remitting multiple sclerosis: evidence from resting-state fMRIYaou Liu, Peipeng Liang, Yunyun Duan, et al.
Brain Sciences|September 28, 2021
Developing a Digital Solution for Remote Assessment in Multiple Sclerosis: From Concept to Software as a Medical DeviceAnneke van der Walt, Helmut Butzkueven, Robert K Shin, et al.
Autoimmunity Reviews|October 15, 2018
What speech can tell us: A systematic review of dysarthria characteristics in Multiple SclerosisGustavo Noffs, Thushara Perera, Scott C Kolbe, et al.
Plos One|March 13, 2026
Study protocol for a mixed methods convergent investigation of family domestic and sexual violence in multiple sclerosis and broader neurology in AustraliaCassie Nesbitt, Genevieve Rayner, Kristen Timmens, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
A role for galanin in human and experimental inflammatory demyelinationDavid C Wraith, Robert Pope, Helmut Butzkueven, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2021
Early treatment delays long-term disability accrual in RRMS: Results from the BMSD networkPietro Iaffaldano, Giuseppe Lucisano, Helmut Butzkueven, et al.
European Radiology|July 2, 2017
Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MSYaou Liu, Yunyun Duan, Jing Huang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 16, 2008
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelinationMichele D Binder, Holly S Cate, Anne L Prieto, et al.
Current Medical Research and Opinion|September 7, 2023
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosisHelmut Butzkueven, Jan Hillert, Merja Soilu-Hänninen, et al.
Pageof 39